Further, the genetic deletion of Galectin-3 reduced neuronal loss and administration of Galectin-3 antibody exerted neuroprotective effects in a preclinical model of traumatic brain injury (Yip et al., 2017) together implicating a detrimental role of Galectin-3 after a brain injury. The gene discussed is LGALS3; the disease is injury.